Need immediate assistance? Call 1-518-730-0559 (Us-Canada Toll Free) or Contact Us

 

Rare Hematology Market – Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2017 – 2022

Table of Content

Chapter 1 Global Outlook

Chapter 2 Global Rare Hematology Disease Treatment Market-Executive Summary

Chapter 3 Global Rare Hematology Disease Treatment Market Overview
3.1 Introduction
      3.1.1 Global Rare Hematology Disease Treatment Market Taxonomy
      3.1.2 Global Rare Hematology Disease Treatment Market Definition
3.2 Global Rare Hematology Disease Treatment Market Size (US$ Mn) and Forecast, 2012-2022
      3.2.1 Global Rare Hematology Disease Treatment Market Y-o-Y Growth
3.3 Global Rare Hematology Disease Treatment Market Dynamics
3.4 Supply Chain
3.5 Cost Structure
3.6 PESTL Analysis
3.7 Product Lifecycle
3.8 Key Regulations
3.9 Biologics License Application (BLA) Products
3.10 List of Distributors
3.11 Key Participants Market Presence (Intensity Map) By Region

Chapter 4 Global Rare Hematology Disease Treatment Market Analysis and Forecast 2012-2022
4.1 Global Rare Hematology Disease Treatment Market Size and Forecast by Treatment Type, 2012-2022
      4.1.1 Plasma Derived Factors Market Size and Forecast, 2012-2022
              4.1.1.1 Revenue (US$ Mn) Comparison, By Region
              4.1.1.2 Market Share Comparison, By Region
              4.1.1.3 Y-o-Y growth Comparison, By Region
      4.1.2 Recombinant Factors Market Size and Forecast, 2012-2022
              4.1.2.1 Revenue (US$ Mn) Comparison, By Region
              4.1.2.2 Market Share Comparison, By Region
              4.1.2.3 Y-o-Y growth Comparison, By Region
4.2 Global Rare Hematology Disease Treatment Market Size and Forecast by Indication, 2012-2022
      4.2.1 Hemophilia A Disease Treatment Market Size and Forecast, 2012-2022
              4.2.1.1 Revenue (US$ Mn) Comparison, By Region
              4.2.1.2 Market Share Comparison, By Region
              4.2.1.3 Y-o-Y growth Comparison, By Region
      4.2.2 Hemophilia B Disease Treatment Market Size and Forecast, 2012-2022
              4.2.2.1 Revenue (US$ Mn) Comparison, By Region
              4.2.2.2 Market Share Comparison, By Region
              4.2.2.3 Y-o-Y growth Comparison, By Region
      4.2.3 Von Wilebrand Disease Treatment Market Size and Forecast, 2012-2022
              4.2.3.1 Revenue (US$ Mn) Comparison, By Region
              4.2.3.2 Market Share Comparison, By Region
              4.2.3.3 Y-o-Y growth Comparison, By Region
      4.2.4 Acquired Hemophilia A Disease Treatment Market Size and Forecast, 2012-2022
              4.2.4.1 Revenue (US$ Mn) Comparison, By Region
              4.2.4.2 Market Share Comparison, By Region
              4.2.4.3 Y-o-Y growth Comparison, By Region
      4.2.5 Other Disease Treatment Market Size and Forecast, 2012-2022
              4.2.5.1 Revenue (US$ Mn) Comparison, By Region
              4.2.5.2 Market Share Comparison, By Region
              4.2.5.3 Y-o-Y growth Comparison, By Region
4.3 Global Rare Hematology Disease Treatment Market Size and Forecast by Age Group, 2012-2022
      4.3.1 Global Rare Hematology Disease Treatment Market for Adult (18+) Market Size and Forecast, 2012-2022
              4.3.1.1 Revenue (US$ Mn) Comparison, By Region
              4.3.1.2 Market Share Comparison, By Region
              4.3.1.3 Y-o-Y growth Comparison, By Region
      4.3.2 Global Rare Hematology Disease Treatment Market for Pediatric (0-17) Market Size and Forecast, 2012-2022
              4.3.2.1 Revenue (US$ Mn) Comparison, By Region
              4.3.2.2 Market Share Comparison, By Region
              4.3.2.3 Y-o-Y growth Comparison, By Region

Chapter 5 North America Rare Hematology Disease Treatment Market Analysis and Forecast, By Country, 2012-2022
5.1 North America Rare Hematology Disease Treatment Market Size and Forecast, 2012-2022
      5.1.1 Revenue (US$ Mn) Comparison, By Treatment Type
      5.1.2 Revenue (US$ Mn) Comparison, By Indication
      5.1.3 Revenue (US$ Mn) Comparison, By Age Group
5.2 US Rare Hematology Disease Treatment Market Size and Forecast, 2012-2022
      5.2.1 Revenue (US$ Mn) Comparison, By Treatment Type
      5.2.2 Revenue (US$ Mn) Comparison, By Indication
      5.2.3 Revenue (US$ Mn) Comparison, By Age Group
5.3 Canada Rare Hematology Disease Treatment Market Size and Forecast, 2012-2022
      5.3.1 Revenue (US$ Mn) Comparison, By Treatment Type
      5.3.2 Revenue (US$ Mn) Comparison, By Indication
      5.3.3 Revenue (US$ Mn) Comparison, By Age Group

Chapter 6 Latin America Rare Hematology Disease Treatment Market Analysis and Forecast, By Country, 2012-2022
6.1 Latin America Rare Hematology Disease Treatment Market Size and Forecast, 2012-2022
      6.1.1 Revenue (US$ Mn) Comparison, By Treatment Type
      6.1.2 Revenue (US$ Mn) Comparison, By Indication
      6.1.3 Revenue (US$ Mn) Comparison, By Age Group
6.2 Brazil Rare Hematology Disease Treatment Market Size and Forecast, 2012-2022
      6.2.1 Revenue (US$ Mn) Comparison, By Treatment Type
      6.2.2 Revenue (US$ Mn) Comparison, By Indication
      6.2.3 Revenue (US$ Mn) Comparison, By Age Group
6.3 Mexico Rare Hematology Disease Treatment Market Size and Forecast, 2012-2022
      6.3.1 Revenue (US$ Mn) Comparison, By Treatment Type
      6.3.2 Revenue (US$ Mn) Comparison, By Indication
      6.3.3 Revenue (US$ Mn) Comparison, By Age Group
6.4 Rest of Latin America Rare Hematology Disease Treatment Market Size and Forecast, 2012-2022
      6.4.1 Revenue (US$ Mn) Comparison, By Treatment Type
      6.4.2 Revenue (US$ Mn) Comparison, By Indication
      6.4.3 Revenue (US$ Mn) Comparison, By Age Group

Chapter 7 Europe Rare Hematology Disease Treatment Market Analysis and Forecast, By Country, 2012-2022
7.1 Europe Rare Hematology Disease Treatment Market Size and Forecast, 2012-2022
      7.1.1 Revenue (US$ Mn) Comparison, By Treatment Type
      7.1.2 Revenue (US$ Mn) Comparison, By Indication
      7.1.3 Revenue (US$ Mn) Comparison, By Age Group
7.2 Germany Rare Hematology Disease Treatment Market Size and Forecast, 2012-2022
      7.2.1 Revenue (US$ Mn) Comparison, By Treatment Type
      7.2.2 Revenue (US$ Mn) Comparison, By Indication
      7.2.3 Revenue (US$ Mn) Comparison, By Age Group
7.3 UK Rare Hematology Disease Treatment Market Size and Forecast, 2012-2022
      7.3.1 Revenue (US$ Mn) Comparison, By Treatment Type
      7.3.2 Revenue (US$ Mn) Comparison, By Indication
      7.3.3 Revenue (US$ Mn) Comparison, By Age Group
7.4 France Rare Hematology Disease Treatment Market Size and Forecast, 2012-2022
      7.4.1 Revenue (US$ Mn) Comparison, By Treatment Type
      7.4.2 Revenue (US$ Mn) Comparison, By Indication
      7.4.3 Revenue (US$ Mn) Comparison, By Age Group
7.5 Spain Rare Hematology Disease Treatment Market Size and Forecast, 2012-2022
      7.5.1 Revenue (US$ Mn) Comparison, By Treatment Type
      7.5.2 Revenue (US$ Mn) Comparison, By Indication
      7.5.3 Revenue (US$ Mn) Comparison, By Age Group
7.6 Italy Rare Hematology Disease Treatment Market Size and Forecast, 2012-2022
      7.6.1 Revenue (US$ Mn) Comparison, By Treatment Type
      7.6.2 Revenue (US$ Mn) Comparison, By Indication
      7.6.3 Revenue (US$ Mn) Comparison, By Age Group
7.7 Rest of Europe Rare Hematology Disease Treatment Market Size and Forecast, 2012-2022
      7.7.1 Revenue (US$ Mn) Comparison, By Treatment Type
      7.7.2 Revenue (US$ Mn) Comparison, By Indication
      7.7.3 Revenue (US$ Mn) Comparison, By Age Group

Chapter 8 Japan Rare Hematology Disease Treatment Market Analysis and Forecast, By Country, 2012-2022
8.1 Japan Rare Hematology Disease Treatment Market Size and Forecast, 2012-2022
      8.1.1 Revenue (US$ Mn) Comparison, By Treatment Type
      8.1.2 Revenue (US$ Mn) Comparison, By Indication
      8.1.3 Revenue (US$ Mn) Comparison, By Age Group

Chapter 9 APEJ Rare Hematology Disease Treatment Market Analysis and Forecast, By Country, 2012-2022
9.1 APEJ Rare Hematology Disease Treatment Market Size and Forecast, 2012-2022
      9.1.1 Revenue (US$ Mn) Comparison, By Treatment Type
      9.1.2 Revenue (US$ Mn) Comparison, By Indication
      9.1.3 Revenue (US$ Mn) Comparison, By Age Group
9.2 China Rare Hematology Disease Treatment Market Size and Forecast, 2012-2022
      9.2.1 Revenue (US$ Mn) Comparison, By Treatment Type
      9.2.2 Revenue (US$ Mn) Comparison, By Indication
      9.2.3 Revenue (US$ Mn) Comparison, By Age Group
9.3 India Rare Hematology Disease Treatment Market Size and Forecast, 2012-2022
      9.3.1 Revenue (US$ Mn) Comparison, By Treatment Type
      9.3.2 Revenue (US$ Mn) Comparison, By Indication
      9.3.3 Revenue (US$ Mn) Comparison, By Age Group
9.4 ASEAN Rare Hematology Disease Treatment Market Size and Forecast, 2012-2022
      9.4.1 Revenue (US$ Mn) Comparison, By Treatment Type
      9.4.2 Revenue (US$ Mn) Comparison, By Indication
      9.4.3 Revenue (US$ Mn) Comparison, By Age Group
9.5 Australia & New Zealand Rare Hematology Disease Treatment Market Size and Forecast, 2012-2022
      9.5.1 Revenue (US$ Mn) Comparison, By Treatment Type
      9.5.2 Revenue (US$ Mn) Comparison, By Indication
      9.5.3 Revenue (US$ Mn) Comparison, By Age Group
9.6 Rest of APEJ Rare Hematology Disease Treatment Market Size and Forecast, 2012-2022
      9.6.1 Revenue (US$ Mn) Comparison, By Treatment Type
      9.6.2 Revenue (US$ Mn) Comparison, By Indication
      9.6.3 Revenue (US$ Mn) Comparison, By Age Group

Chapter 10 MEA Rare Hematology Disease Treatment Market Analysis and Forecast, By Country, 2012-2022
10.1 MEA Rare Hematology Disease Treatment Market Size and Forecast, 2012-2022
      10.1.1 Revenue (US$ Mn) Comparison, By Treatment Type
      10.1.2 Revenue (US$ Mn) Comparison, By Indication
      10.1.3 Revenue (US$ Mn) Comparison, By Age Group
10.2 GCC Countries Rare Hematology Disease Treatment Market Size and Forecast, 2012-2022
      10.2.1 Revenue (US$ Mn) Comparison, By Treatment Type
      10.2.2 Revenue (US$ Mn) Comparison, By Indication
      10.2.3 Revenue (US$ Mn) Comparison, By Age Group
10.3 South Africa Rare Hematology Disease Treatment Market Size and Forecast, 2012-2022
      10.3.1 Revenue (US$ Mn) Comparison, By Treatment Type
      10.3.2 Revenue (US$ Mn) Comparison, By Indication
      10.3.3 Revenue (US$ Mn) Comparison, By Age Group
10.4 Rest of MEA Rare Hematology Disease Treatment Market Size and Forecast, 2012-2022
      10.4.1 Revenue (US$ Mn) Comparison, By Treatment Type
      10.4.2 Revenue (US$ Mn) Comparison, By Indication
      10.4.3 Revenue (US$ Mn) Comparison, By Age Group

Chapter 11 Global Rare Hematology Disease Treatment Market – Competitive Landscape and Company Profiles
11.1 Global Rare Hematology Disease Treatment Market – Company Share Analysis
11.2 Global Rare Hematology Disease Treatment Market – Competitive Landscape
11.3 Global Rare Hematology Disease Treatment Market – Company Profiles
      11.3.1 Shire plc
              11.3.1.1 Company Overview
              11.3.1.2 Product Overview
              11.3.1.3 Key Financials
              11.3.1.4 Key Developments
              11.3.1.5 SWOT Analysis
      11.3.2 Biogen Inc.
              11.3.2.1 Company Overview
              11.3.2.2 Product Overview
              11.3.2.3 Key Financials
              11.3.2.4 Key Developments
              11.3.2.5 SWOT Analysis
      11.3.3 Novo Nordisk A/S
              11.3.3.1 Company Overview
              11.3.3.2 Product Overview
              11.3.3.3 Key Financials
              11.3.3.4 Key Developments
              11.3.3.5 SWOT Analysis
      11.3.4 Bayer Healthcare AG
              11.3.4.1 Company Overview
              11.3.4.2 Product Overview
      11.3.5 CSL Behring LLC
              11.3.5.1 Company Overview
              11.3.5.2 Product Overview
      11.3.6 Pfizer Inc.
              11.3.6.1 Company Overview
              11.3.6.2 Product Overview
              11.3.6.3 Key Financials
              11.3.6.4 Key Developments
              11.3.6.5 SWOT Analysis
      11.3.7 PRA Health Sciences
              11.3.7.1 Company Overview
              11.3.7.2 Product Overview
              11.3.7.3 Key Financials
              11.3.7.4 Key Developments
      11.3.8 Celgene Corporation
              11.3.8.1 Company Overview
              11.3.8.2 Product Overview
              11.3.8.3 Key Financials
              11.3.8.4 Key Developments
              11.3.8.5 SWOT Analysis
      11.3.9 Alexion Pharmaceuticals, Inc.
              11.3.9.1 Company Overview
              11.3.9.2 Product Overview
              11.3.9.3 Key Financials
              11.3.9.4 Key Developments
              11.3.9.5 SWOT Analysis
      11.3.10 Amgen Inc.
              11.3.10.1 Company Overview
              11.3.10.2 Product Overview
              11.3.10.3 Key Financials
              11.3.10.4 SWOT Analysis

Chapter 12 TMR Research Methodology

Chapter 13 Disclaimer and Contact information

Custom Market Research Services

MRRSE offers custom market research services that help clients to get information on their business scenario required where syndicated solutions are not enough.

Get A Free Custom Research Quote